Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL6009610 | 0.91 | — | — | |
| Iodide SCHEMBL6010480 | 0.84 | MEN1 (0.33) | NPC1RAB9A | |
| SCHEMBL5287538 | 0.80 | HTT (0.46) | NPC1RAB9ASMN1; SMN2HIF1ALMNA | |
| SCHEMBL1137199 | 0.80 | HTT (0.46) | NPC1RAB9ASMN1; SMN2HIF1ALMNA | |
| SCHEMBL5090775 | 0.80 | HTT (0.46) | NPC1RAB9ASMN1; SMN2HIF1ALMNA | |
| SCHEMBL5086772 | 0.80 | HTT (0.46) | NPC1RAB9ASMN1; SMN2HIF1ALMNA | |
| SCHEMBL9935730 | 0.80 | HTT (0.46) | NPC1RAB9ASMN1; SMN2HIF1ALMNA | |
| SCHEMBL2328683 | 0.80 | HTT (0.46) | NPC1RAB9ASMN1; SMN2HIF1ALMNA | |
| SCHEMBL9902243 | 0.80 | HTT (0.46) | NPC1RAB9ASMN1; SMN2HIF1ALMNA | |
| SCHEMBL363480 | 0.80 | HTT (0.46) | NPC1RAB9ASMN1; SMN2HIF1ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009024312-A2 | METHOD FOR THE PRODUCTION AND STABILIZATION OF FUNCTIONAL METAL NANOPARTICLES IN IONIC LIQUIDS | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2009-02-26 | — | — | WO | disclosed |